Altered sphingoid base profiles predict compromised membrane structure and permeability in atopic dermatitis

Journal of Dermatological Science

Volumn 72, Issue 3, 2013, Pages 296-303

  Loiseau, Nicolas ^a,b,c,d   Obata, Yasuko ^e   Moradian, Sam ^a,b,c   Sano, Hiromu ^e   Yoshino, Saeko ^f   Aburai, Kenichi ^f   Takayama, Kozo ^e   Sakamoto, Kazutami ^f,g   Holleran, Walter M ^a,b,c   Elias, Peter M ^a,b,c   Uchida, Yoshikazu ^a,b,c,h  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b SAN FRANCISCO VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c NORTHERN CALIFORNIA INSTITUTE FOR RESEARCH AND EDUCATION   (United States)

^d TOXALIM RESEARCH CENTRE IN FOOD TOXICOLOGY   (France)

^e HOSHI UNIVERSITY   (Japan)

^f TOKYO UNIVERSITY OF SCIENCE   (Japan)

^g CHIBA INSTITUTE OF SCIENCE   (Japan)

^h NONE   (United States)

Author keywords

Atopic dermatitis; Barrier; Ceramide; Sphingosine

Indexed keywords

AMINOALCOHOL; CARBOXYFLUORESCEIN; CERAMIDE; CHOLESTEROL; FATTY ACID; SPHINGANINE; SPHINGOID BASE; SPHINGOSINE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; ATOPIC DERMATITIS; CELL STRUCTURE; CHEMICAL STRUCTURE; CONTROLLED STUDY; CYTOPLASM VESICLE; DIFFERENTIAL SCANNING CALORIMETRY; ENCAPSULATION; LIPID ANALYSIS; LIPID BLOOD LEVEL; LIPID COMPOSITION; LIPOGENESIS; MEMBRANE PERMEABILITY; MEMBRANE STRUCTURE; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN LIPID INTERACTION; STRATUM CORNEUM; THERMAL ANALYSIS;

2,5-CARBOXYFLUORESCEIN; AD; ATOPIC DERMATITIS; BARRIER; CER; CERAMIDE; CFC; DIFFERENTIAL SCANNING CALORIMETRY; DSC; FFA; FREE FATTY ACIDS; LV; SA; SC; SDS; SO; SODIUM DODECYL SULFATE; SPHINGANINE; SPHINGOSINE; STRATUM CORNEUM; UNILAMELLAR VESICLES;

ANIMALS; CELL MEMBRANE PERMEABILITY; CERAMIDES; DERMATITIS, ATOPIC; DISEASE MODELS, ANIMAL; EPIDERMIS; HUMANS; MICE; SPHINGOSINE;

EID: 84887154958     PISSN: 09231811     EISSN: 1873569X     Source Type: Journal    
DOI: 10.1016/j.jdermsci.2013.08.003     Document Type: Article

References (53)

1. Elias P.M., Menon G.K. Structural and lipid biochemical correlates of the epidermal permeability barrier. Adv Lipid Res 1991, 24:1-26.
2. Elias P.M. Stratum corneum defensive functions: an integrated view. J Invest Dermatol 2005, 125:183-200.
3. Bouwstra J., Pilgram G., Gooris G., Koerten H., Ponec M. New aspects of the skin barrier organization. Skin Pharmacol Appl Skin Physiol 2001, 14:52-62.
4. Schürer N.Y., Plewig G., Elias P.M. Stratum corneum lipid function. Dermatologica 1991, 183:77-94.
5. Holleran W.M., Takagi Y., Uchida Y. Epidermal sphingolipids: metabolism, function, and role(s) in skin disorders. FEBS Lett 2006, 23:5456-5466.
6. Bouwstra J.A., Honeywell-Nguyen P.L., Gooris G.S., Ponec M. Structure of the skin barrier and its modulation by vesicular formulations. Prog Lipid Res 2003, 42:1-36.
7. Uchida Y., Holleran W.M. Omega-O-acylceramide, a lipid essential for mammalian survival. J Dermatol Sci 2008, 51:77-87.
8. Wertz P.W., Downing D.T. Ceramidase activity in porcine epidermis. FEBS Lett 1990, 268:110-112.
9. Houben E., Uchida Y., Nieuwenhuizen W.F., De Paepe K., Vanhaecke T., Holleran W.M., et al. Kinetic characteristics of acidic and alkaline ceramidase in human epidermis. Skin Pharmacol Physiol 2007, 20:187-194.
10. Lin T.K., Crumrine D., Ackerman L.D., Santiago J.L., Roelandt T., Uchida Y., et al. Cellular changes that accompany shedding of human corneocytes. J Invest Dermatol 2012, 132:2430-2439.
11. Bibel D.J., Aly R., Shinefield H.R. Antimicrobial activity of sphingosines. J Invest Dermatol 1992, 98:269-273.
12. Drake D.R., Brogden K.A., Dawson D.V., Wertz PW: Thematic review series: skin lipids. Antimicrobial lipids at the skin surface. J Lipid Res 2008, 49:4-11.
13. Hannun Y.A., Loomis C.R., Bell RM: Protein kinase C activation in mixed micelles. Mechanistic implications of phospholipid, diacylglycerol, and calcium interdependencies. J Biol Chem 1986, 261:7184-7190.
14. Arnold R.S., Newton AC: Inhibition of the insulin receptor tyrosine kinase by sphingosine. Biochemistry 1991, 30:7747-7754.
15. Mullmann T.J., Siegel M.I., Egan R.W., Billah M.M. Sphingosine inhibits phosphatidate phosphohydrolase in human neutrophils by a protein kinase C-independent mechanism. J Biol Chem 1991, 266:2013-2016.
16. Min J.K., Yoo H.S., Lee E.Y., Lee W.J., Lee Y.M. Simultaneous quantitative analysis of sphingoid base 1-phosphates in biological samples by o-phthalaldehyde precolumn derivatization after dephosphorylation with alkaline phosphatase. Anal Biochem 2002, 303:167-175.
17. Contreras F.X., Sot J., Alonso A., Goni F.M. Sphingosine increases the permeability of model and cell membranes. Biophys J 2006, 90:4085-4092.
18. Boguniewicz M., Leung D.Y. Atopic dermatitis: a disease of altered skin barrier and immune dysregulation. Immunol Rev 2011, 242:233-246.
19. Hou M., Man M., Man W., Zhu W., Hupe M., Park K., et al. Topical hesperidin improves epidermal permeability barrier function and epidermal differentiation in normal murine skin. Exp Dermatol 2012, 21:337-340.
20. Elias P.M., Steinhoff M. Outside-to-inside" (and now back to "outside") pathogenic mechanisms in atopic dermatitis. J Invest Dermatol 2008, 128:1067-1070.
21. Imokawa G., Abe A., Jin K., Higaki Y., Kawashima M., Hidano A. Decreased level of ceramides in stratum corneum of atopic dermatitis: an etiologic factor in atopic dry skin?. J Invest Dermatol 1991, 96:523-526.
22. Bleck O., Abeck D., Ring J., Hoppe U., Vietzke J.P., Wolber R., et al. Two ceramide subfractions detectable in Cer(AS) position by HPTLC in skin surface lipids of non-lesional skin of atopic eczema. J Invest Dermatol 1999, 113:894-900.
23. Macheleidt O., Kaiser H.W., Sandhoff K. Deficiency of epidermal protein-bound omega-hydroxyceramides in atopic dermatitis. J Invest Dermatol 2002, 119:166-173.
24. Yoon J.S., Nishifuji K., Sasaki A., Ide K., Ishikawa J., Yoshihara T., et al. Alteration of stratum corneum ceramide profiles in spontaneous canine model of atopic dermatitis. Exp Dermatol 2011, 20:732-736.
25. Chamlin S.L., Frieden I.J., Fowler A., Williams M., Kao J., Sheu M., et al. Ceramide-dominant, barrier-repair lipids improve childhood atopic dermatitis. Arch Dermatol 2001, 137:1110-1112.
26. Sugarman J.L., Parish L.C. Efficacy of a lipid-based barrier repair formulation in moderate-to-severe pediatric atopic dermatitis. J Drugs Dermatol 2009, 8:1106-1111.
27. Arikawa J., Ishibashi M., Kawashima M., Takagi Y., Ichikawa Y., Imokawa G. Decreased levels of sphingosine, a natural antimicrobial agent, may be associated with vulnerability of the stratum corneum from patients with atopic dermatitis to colonization by Staphylococcus aureus. J Invest Dermatol 2002, 119:433-439.
28. Houben E., Holleran W.M., Yaginuma T., Mao C., Obeid L.M., Rogiers V., et al. Differentiation-associated expression of ceramidase isoforms in cultured keratinocytes and epidermis. J Lipid Res 2006, 47:1063-1070.
29. Ohnishi Y., Okino N., Ito M., Imayama S. Ceramidase activity in bacterial skin flora as a possible cause of ceramide deficiency in atopic dermatitis. Clin Diagn Lab Immunol 1999, 6:101-104.
30. Kita K., Sueyoshi N., Okino N., Inagaki M., Ishida H., Kiso M., et al. Activation of bacterial ceramidase by anionic glycerophospholipids: possible involvement in ceramide hydrolysis on atopic skin by Pseudomonas ceramidase. Biochem J 2002, 362:619-626.
31. Fartasch M., Bassukas I.D., Diepgen T.L. Disturbed extruding mechanism of lamellar bodies in dry non-eczematous skin of atopics. Br J Dermatol 1992, 127:221-227.
32. Man M.Q., Hatano Y., Lee S.H., Man M., Chang S., Feingold K.R., et al. Characterization of a hapten-induced, murine model with multiple features of atopic dermatitis: structural, immunologic, and biochemical changes following single versus multiple oxazolone challenges. J Invest Dermatol 2008, 128:79-86.
33. Hatano Y., Man M.-Q., Uchida Y., Crumrine D., Scharschmidt T.C., Kim E.G., et al. Maintenance of an acidic stratum corneum prevents emergence of murine atopic dermatitis. J Invest Dermatol 2009, 129:1824-1835.
34. Hatano Y., Man M.Q., Uchida Y., Crumrine D., Mauro T.M., Feingold K.R., et al. Murine atopic dermatitis responds to peroxisome proliferator-activated receptors alpha and beta/delta (but not gamma) and liver X receptor activators. J Allergy Clin Immunol 2010, 125:160-169.
35. Hara M., Uchida Y., Haratake A., Mimura K., Hamanaka S. Galactocerebroside and not glucocerebroside or ceramide stimulate epidermal beta-glucocerebrosidase activity. J Dermatol Sci 1998, 16:111-119.
36. Folch J., Lees M., Sloane Stanley G.H. A simple method for the isolation and purification of total lipides from animal tissues. J Biol Chem 1957, 226:497-509.
37. Uchida Y., Hama H., Alderson N.L., Douangpanya S., Wang Y., Crumrine D.A., et al. Fatty acid 2-hydroxylase, encoded by FA2H, accounts for differentiation-associated increase in 2-OH ceramides during keratinocyte differentiation. J Biol Chem 2007, 282:13211-13219.
38. de la Maza A., Parra J.L. Solubilizing effects caused by the nonionic surfactant dodecylmaltoside in phosphatidylcholine liposomes. Biophys J 1997, 72:1668-1675.
39. Otake K., Shimomura T., Goto T., Imura T., Furuya T., Yoda S., et al. Preparation of liposomes using an improved supercritical reverse phase evaporation method. Langmuir 2006, 22:2543-2550.
40. Di Nardo A., Wertz P., Giannetti A., Seidenari S. Ceramide and cholesterol composition of the skin of patients with atopic dermatitis. Acta Derm Venereol 1998, 78:27-30.
41. Hatta I., Ohta N., Inoue K., Yagi N. Coexistence of two domains in intercellular lipid matrix of stratum corneum. Biochim Biophys Acta 2006, 1758:1830-1836.
42. Elias P.M., Hatano Y., Williams M.L. Basis for the barrier abnormality in atopic dermatitis: outside-inside-outside pathogenic mechanisms. J Allergy Clin Immunol 2008, 121:1337-1343.
43. Gruber R., Elias P.M., Crumrine D., Lin T.K., Brandner J.M., Hachem J.P., et al. Filaggrin genotype in ichthyosis vulgaris predicts abnormalities in epidermal structure and function. Am J Pathol 2011, 178:2252-2263.
44. Scharschmidt T.C., Man M.Q., Hatano Y., Crumrine D., Gunathilake R., Sundberg J.P., et al. Filaggrin deficiency confers a paracellular barrier abnormality that reduces inflammatory thresholds to irritants and haptens. J Allergy Clin Immunol 2009, 124:496-506. 506 e491-496.
45. Wertz P.W., Downing D.T. Ceramides of pig epidermis: structure determination. J Lipid Res 1983, 24:759-765.
46. SPonec M., Weerheim A., Lankhorst P., Wertz P. New acylceramide in native and reconstructed epidermis. J Invest Dermatol 2003, 120:581-588.
47. Stewart M.E., Downing D.T. A new 6-hydroxy-4-sphingenine-containing ceramide in human skin. J Lipid Res 1999, 40:1434-1439.
48. Bouwstra J.A., Dubbelaar F.E., Gooris G.S., Ponec M. The lipid organisation in the skin barrier. Acta Derm Venereol Suppl 2000, 208:23-30.
49. Damien F., Boncheva M. The extent of orthorhombic lipid phases in the stratum corneum determines the barrier efficiency of human skin in vivo. J Invest Dermatol 2010, 130:611-614.
50. Thakoersing V.S., van Smeden J., Mulder A.A., Vreeken R.J., El Ghalbzouri A., Bouwstra J.A. Increased presence of monounsaturated fatty acids in the stratum corneum of human skin equivalents. J Invest Dermatol 2013, 133:59-67.
51. Janssens M., van Smeden J., Gooris G.S., Bras W., Portale G., Caspers P.J., et al. Increase in short-chain ceramides correlates with an altered lipid organization and decreased barrier function in atopic eczema patients. J Lipid Res 2012, 53:2755-2766.
52. Motta S., Monti M., Sesana S., Caputo R., Carelli S., Ghidoni R. Ceramide composition of the psoriatic scale. Biochim Biophys Acta 1993, 1182:147-151.
53. Robson K.J., Stewart M.E., Michelsen S., Lazo N.D. Downing DT: 6-Hydroxy-4-sphingenine in human epidermal ceramides. J Lipid Res 1994, 35:2060-2068.